The pharmacokinetics of S-warfarin in healthy subjects carrying different CYP2C9 genotypes.

被引：0
|
作者：
Shaoul, H. [1 ]
Blotnick, S. [1 ]
Muszkat, M. [1 ]
Caraco, Y. [1 ]
机构：
[1] Hadassah Univ Hosp, Jerusalem, Israel
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [31] Effects of genetic polymorphism of CYP2C9 on the pharmacokinetics of lornoxicam in healthy Korean subjects.
    Bac, J.
    Kim, N.
    Lee, H.
    Lee, J.
    Jung, D.
    Kim, M.
    Jang, C.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S33 - S34
  • [32] Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects
    Gardin, Anne
    Ufer, Mike
    Legangneux, Eric
    Rossato, Gianluca
    Jin, Yi
    Su, Zhenzhong
    Pal, Parasar
    Li, Wenkui
    Shakeri-Nejad, Kasra
    CLINICAL PHARMACOKINETICS, 2019, 58 (03) : 349 - 361
  • [33] Effects of CYP2C9 polymorphism on the pharmacokinetics and pharmacodynamics of meloxicam in healthy korean subjects.
    Bae, J.
    Kim, M.
    Song, Y.
    Sa, J.
    Choi, C.
    Jang, C.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S31 - S31
  • [34] Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects
    Anne Gardin
    Mike Ufer
    Eric Legangneux
    Gianluca Rossato
    Yi Jin
    Zhenzhong Su
    Parasar Pal
    Wenkui Li
    Kasra Shakeri-Nejad
    Clinical Pharmacokinetics, 2019, 58 : 349 - 361
  • [35] CYP2C9 genetic polymorphisms significantly affected the pharmacokinetics of flurbiprofen in healthy Korean subjects
    Lim, Hye-Jin
    Kim, Dong-Hyun
    Byeon, Ji-Yeong
    Kim, Young-Hoon
    Kim, Se-Hyung
    PHARMACOTHERAPY, 2015, 35 (11): : E316 - E316
  • [36] Frequency of CYP2C9 genotypes among Omani patients receiving warfarin
    Tanira, MO
    Al-Mukhaini, MK
    Al-Hinai, AT
    Al Balushi, KA
    Ahmed, IS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 639 - 639
  • [37] PBPK modeling for irbesartan in different CYP2C9 genotypes
    Kang, Pureum
    Cho, Chang-Keun
    Ko, Eunvin
    Mu, Chou Yen
    Lee, Seok-Yong
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 249 - 250
  • [38] Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects
    Lu, Sijie
    Nand, R. A.
    Yang, J. S.
    Chen, Gang
    Gross, A. S.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (03) : 285 - 296
  • [39] Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects
    Sijie Lu
    R. A. Nand
    J. S. Yang
    Gang Chen
    A. S. Gross
    European Journal of Clinical Pharmacology, 2018, 74 : 285 - 296
  • [40] CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers
    Pedro Dorado
    Roland Berecz
    Maria-Jesús Norberto
    Ümit Yasar
    Marja-Liisa Dahl
    Adrián LLerena
    European Journal of Clinical Pharmacology, 2003, 59 : 221 - 225
12345